Coeptis Therapeutics Stock Price Prediction

COEP Stock  USD 7.01  1.29  22.55%   
As of today, the RSI of Coeptis Therapeutics' share price is approaching 36 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Coeptis Therapeutics, making its price go up or down.

Oversold Vs Overbought

36

 
Oversold
 
Overbought
The successful prediction of Coeptis Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Coeptis Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Coeptis Therapeutics' stock price prediction:
Wall Street Target Price
3
Quarterly Revenue Growth
15.637
Using Coeptis Therapeutics hype-based prediction, you can estimate the value of Coeptis Therapeutics from the perspective of Coeptis Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Coeptis Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Coeptis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Coeptis Therapeutics after-hype prediction price

    
  USD 5.72  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Coeptis Therapeutics Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Coeptis Stock, please use our How to Invest in Coeptis Therapeutics guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Coeptis Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.255.0418.23
Details
1 Analysts
Consensus
LowTargetHigh
3.193.503.89
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Coeptis Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Coeptis Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Coeptis Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Coeptis Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Coeptis Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Coeptis Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Coeptis Therapeutics' historical news coverage. Coeptis Therapeutics' after-hype downside and upside margins for the prediction period are 0.29 and 18.91, respectively. We have considered Coeptis Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
7.01
5.72
After-hype Price
18.91
Upside
Coeptis Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Coeptis Therapeutics is based on 3 months time horizon.

Coeptis Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Coeptis Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Coeptis Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Coeptis Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.87 
13.45
  1.42 
  0.19 
5 Events / Month
14 Events / Month
In about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
7.01
5.72
0.00 
1,770  
Notes

Coeptis Therapeutics Hype Timeline

Coeptis Therapeutics is currently traded for 7.01. The entity has historical hype elasticity of 1.42, and average elasticity to hype of competition of -0.19. Coeptis is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 1.87%. %. The volatility of related hype on Coeptis Therapeutics is about 13383.08%, with the expected price after the next announcement by competition of 6.82. About 19.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.47. Coeptis Therapeutics last dividend was issued on the 6th of August 2020. The entity had 1:40000 split on the 6th of August 2020. Given the investment horizon of 90 days the next forecasted press release will be in about 5 days.
Check out Coeptis Therapeutics Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Coeptis Stock, please use our How to Invest in Coeptis Therapeutics guide.

Coeptis Therapeutics Related Hype Analysis

Having access to credible news sources related to Coeptis Therapeutics' direct competition is more important than ever and may enhance your ability to predict Coeptis Therapeutics' future price movements. Getting to know how Coeptis Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Coeptis Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ICULMF Acquisition Opportunities(0.13)10 per month 0.00 (0.17) 7.98 (7.11) 27.11 
VIRIVirios Therapeutics Llc(1.13)2 per month 0.00 (0.01) 15.01 (18.49) 69.76 
ZVSAZyVersa Therapeutics 0.01 5 per month 0.00 (0.07) 12.73 (7.89) 78.93 
SONNSonnet Biotherapeutics Holdings(0.64)7 per month 0.00 (0.25) 9.38 (11.40) 37.58 
REVBRevelation Biosciences(0.29)5 per month 7.81  0.01  17.95 (7.84) 73.15 
CMNDClearmind Medicine Common(0.13)3 per month 5.08  0.07  10.00 (9.45) 50.29 
HILSHillstream Biopharma 0.03 3 per month 0.00 (0.05) 8.33 (7.89) 113.15 
MGTAMagenta Therapeutics(0.02)2 per month 3.40  0.03  5.88 (4.29) 16.99 
QNRXQuoin Pharmaceuticals Ltd(0.05)10 per month 5.64  0.1  27.27 (9.59) 74.46 
GNLXGenelux Common(0.28)6 per month 5.08  0.06  8.15 (7.07) 40.11 
CMRAComera Life Sciences 0.00 0 per month 0.00 (0) 13.95 (12.70) 30.28 
DYAIDyadic International(0.04)7 per month 4.23  0.15  12.08 (8.59) 45.05 
CINGCingulate 0.14 4 per month 3.92  0.03  8.76 (7.60) 38.00 
MNPRMonopar Therapeutics 0.88 10 per month 8.06  0.12  14.91 (11.81) 653.56 
YSYS Old 0.12 2 per month 0.00 (0.09) 10.29 (10.53) 36.81 
ALLRAllarity Therapeutics(0.06)8 per month 0.00 (0.14) 6.19 (8.12) 27.90 
KRBPKiromic Biopharma(0.24)3 per month 0.00 (0.02) 12.04 (10.96) 65.24 
ADTXAditxt Inc(0.01)7 per month 0.00 (0.45) 5.71 (18.06) 39.19 
PALIPalisade Bio(0.15)7 per month 0.00 (0.04) 8.96 (12.26) 93.57 
PSTVPlus Therapeutics(0.02)10 per month 0.00 (0.01) 7.63 (7.80) 18.02 

Coeptis Therapeutics Additional Predictive Modules

Most predictive techniques to examine Coeptis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Coeptis using various technical indicators. When you analyze Coeptis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Coeptis Therapeutics Predictive Indicators

The successful prediction of Coeptis Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Coeptis Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Coeptis Therapeutics based on analysis of Coeptis Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Coeptis Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Coeptis Therapeutics's related companies.
 2024 2025 (projected)
Graham Number2.031.93
Receivables Turnover1.271.13

Story Coverage note for Coeptis Therapeutics

The number of cover stories for Coeptis Therapeutics depends on current market conditions and Coeptis Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Coeptis Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Coeptis Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Coeptis Therapeutics Short Properties

Coeptis Therapeutics' future price predictability will typically decrease when Coeptis Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Coeptis Therapeutics often depends not only on the future outlook of the potential Coeptis Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Coeptis Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding25.7 M
Cash And Short Term Investments1.5 M

Additional Tools for Coeptis Stock Analysis

When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.